| Authors: |
Mirgh S; Adult Hematolymphoid and BMT unit, Department of Medical Oncology, Tata Memorial Centre, ACTREC, Navi Mumbai, India; Adult Hematolymphoid and BMT Unit, Homi Bhabha National Institute (HBNI), Mumbai, India., Yanamandra U; Department of Internal Medicine (Hematology Division), Armed Forces Medical College (AFMC), Pune, India. Electronic address: udayj2@gmail.com., Vishvanathan GK; Department of Hematology, All India Institute of Medical Sciences (AIIMS), New Delhi, India., Gundeti S; Medical Oncology, Nizam's Institute of Medical Sciences, Hyderabad, India., Khattry N; Adult Hematolymphoid and BMT Unit, Homi Bhabha National Institute (HBNI), Mumbai, India; Clinical Research Centre, ACTREC, Dept of Medical Oncology, Tata Memorial Center, Mumbai, India., John MJ; Clinical Haematology, Haemato-Oncology and Bone Marrow Transplant Unit at Christian Medical College, Ludhiana, Punjab, India., Malhotra P; Clinical Hematology, Post Graduate Institute of Medical Sciences and Research, Chandigarh, India., Menon H; Haematology and Medical Oncology, St Johns National Academy of Health Sciences, India., Das S; Department of Hemato-Oncology and BMT, Jaypee Hospital, Noida, India., Nair R; Clinical Hematology, Tata Medical Center, Kolkata, India., Nair V; Haematology & Bone Marrow Transplant, Apollo Cancer Centre, Ahmedabad, India., Saikia T; Medical Oncology, Head & Neck Cancer Institute of India, Mumbai, India., Kumar SK; Department of Hematology, Mayo Clinic, Rochester, MN. |
